The Division of Hepatology is a multifaceted program that offers the latest clinical treatment and research in one hospital system. With more than 70 million Americans who have chronic liver disease, the number of advanced liver diseases being diagnosed is increasing and, as a result, so is the cost of effective healthcare delivery. In response to this need, substantial advances in treatment options and research have been made. The division integrates all available options into the practice and, where possible, draws from research of the team members.

Clinical expertise

The Division of Hepatology is committed to providing state-of-the-art, high-quality medical care to the diverse population it serves. The division has a robust clinical faculty and members are proud of their proven record of patient satisfaction and high rate of excellent clinical outcomes. The team strives for excellence in clinical care, translational research, and medical education. Residents benefit from seeing a broad spectrum of hepatological cases and are led by highly skilled attending physicians.


David E. Bernstein, MD

  • Chief of Division - Hepatology of Medicine - Gastroenterology, Long Island Jewish Medical Center
  • Chief of Division - Hepatology of Medicine - Gastroenterology, North Shore University Hospital
  • Professor, Hofstra North Shore-LIJ School of Medicine
  • view full profile
Clinical trials & research

The division includes a research program that is fully committed to advancing patient care, teaching and research. The division performs state-of-the-art clinical trials focusing on the treatment of liver disease in order to bring new treatments patients and their families. The general focus of these trials is to gain a better understanding of the nature and behavior of these diseases in an effort to develop more effective treatments.

The researchers at the world-renowned Feinstein Institute for Medical Research are continually making advances in medicine.